Reunion Neuroscience shares are trading higher after the company announced a $13.1 million take-private transaction with MPM BioImpact.
Portfolio Pulse from Benzinga Newsdesk
Reunion Neuroscience announced a $13.1 million take-private transaction with MPM BioImpact, causing its shares to trade higher.
June 01, 2023 | 1:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Reunion Neuroscience's stock price is trading higher after announcing a $13.1 million take-private transaction with MPM BioImpact.
The announcement of the $13.1 million take-private transaction with MPM BioImpact has led to an increase in Reunion Neuroscience's stock price. Investors are likely to view this deal positively, as it indicates a strong partnership and potential growth opportunities for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100